You are here: Industry Insights > API

News List

Wavelength Ups API Production for Essential Respiratory Meds contractpharma
April 21, 2020
Products in demand due to coronavirus pandemic include Midazolam, Cisatracurium, and Rocuronium.
Lasa Supergenerics gets FDA nod for progesterone API expresspharma
April 14, 2020
Progesterone is one of the 26 drugs that had a restriction for exports due to COVID 19 pandemic as a result of India’s import dependency on Chinese suppliers.
American Regent Expands API Ops contractpharma
April 02, 2020
American Regent, a U.S. manufacturer of pharmaceuticals with manufacturing sites in New York and Ohio, will acquire Daiichi Sankyo Altkirch SARL.
Government asks MoEFCC to expedite clearance of API/intermediates expresspharma
March 31, 2020
The Union Government has asked the Ministry of Environment, Forest and Climate Change (MoEFCC) to expedite the prior environmental clearance to projects or activities in respect of APIs/bulk drugs and intermediates.
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment C2 PHARMA
March 27, 2020
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin.
India to set up $1.3bn pharma manufacturing fund, says report europeanpharmaceuticalreview
March 26, 2020
Due to the COVID-19 outbreak, India has decided to invest $1.3 billion into its internal drug manufacturing capabilities, says a new report.
Bengal Chemicals can supply only 10 lakh hydroxy-chloroquine tablets expresspharma
March 26, 2020
PSU pharma company Bengal Chemicals and Pharmaceuticals said it can provide only a maximum of 10 lakh hydroxy-chloroquine tablets due to the shortage of a key component.
Powder Flow: Influence of Powder Properties on Dosing Performance Tim Freeman
March 25, 2020
Dry Powder Inhalers (DPI) are used to deliver a controlled dose of active pharmaceutical ingredient (API) to the deep lung.
Industry players applaud govt’s move to boost manufacturing of APIs, med devices expresspharma
March 24, 2020
The approved scheme will promote bulk drug parks for financing common infrastructure facilities in three bulk drug parks with a financial investment of Rs 3,000 crore in the next five years, the IPA said.
Pharma units in AP, Telengana to be exempted from lockdown expresspharma
March 24, 2020
Government order exempts continuous process units such as pharmaceuticals, APIs etc.